Obstructive lung disease in acute medical patients.

OBJECTIVES To determine the proportion of adult medical patients who have chronic obstructive pulmonary disease (COPD), using the Global initiative for Chronic Obstructive Lung Disease guidelines (GOLD), and its relation to vascular disease. METHODS This is a prospective cross-sectional study of adult patients admitted to acute medical wards. Interviewer administered questionnaire, anthropometric and spirometric measurements were done. RESULTS Spirometry was performed in 720 acute admissions [Mean (SD) age 50.0 (18.9) years, FEV1: 1.98 L (0.83), FEV1/FVC%: 75.1 (11.9)%; males 332 (46.1%), smokers 318 (44%); 43.2% had vascular disease]. Sixty-seven per cent of patients (480) had no airway disease including 35 (4.5%) with chronic cough and sputum with normal spirometry; 89 (12.4%) had asthma and 151 (20.9%) had COPD. Patients with COPD were significantly older [60.3 (16.6) years] than non-COPD patients [47.3 (18.5) years], p < 0.001 and had a greater number of pack years of smoking. A greater percentage of patients with COPD had vascular disease (52%) than the non-COPD patients (40.1%), p = 0.017). Multivariate analysis with vascular disease as outcome variable revealed relationships with older age (p < 0.001) and Indo-Trinidadian ethnicity (p = 0.015), but not with gender (p = 0.321) and smoking (p = 0.442). FEV1% as well as FEV1 showed a significant inverse relationship with vascular disease (p < 0.05). CONCLUSIONS The prevalence of COPD using GOLD guidelines in acute hospital admissions is 20.9%; 11.7% of admissions have chronic sputum or cough with normal spirometry. Vascular disease is more prevalent in those with COPD. Patients admitted to acute medical care with vascular disease may also have COPD.

[1]  D. Price,et al.  COPD screening efforts in primary care: what is the yield? , 2007, Primary care respiratory journal : journal of the General Practice Airways Group.

[2]  Michael J. Allison,et al.  COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. , 2007, Chest.

[3]  A. Mohan,et al.  Clinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unit , 2006, BMC pulmonary medicine.

[4]  N. Anthonisen,et al.  Mortality in COPD: role of comorbidities , 2006, European Respiratory Journal.

[5]  Judith K Jones,et al.  Chronic obstructive pulmonary disease severity and cardiovascular outcomes , 2006, European Journal of Epidemiology.

[6]  D. Mannino,et al.  CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE OLDER ADULT: WHAT BEST DEFINES ABNORMAL LUNG FUNCTION? , 2006 .

[7]  D. Mannino,et al.  Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.

[8]  A. Lindberg,et al.  Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. , 2006, Respiratory medicine.

[9]  Mp Cariappa,et al.  Designing Clinical Research : An Epidemiological Approach , 2006 .

[10]  N. Anthonisen,et al.  Use of spirometry and respiratory drugs in Manitobans over 35 years of age with obstructive lung diseases. , 2005, Canadian respiratory journal.

[11]  A. Møller,et al.  [Smoking cessation and chronic obstructive pulmonary disease]. , 2004, Ugeskrift for laeger.

[12]  F Neukirch,et al.  An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages , 2004, Thorax.

[13]  T. Takishima,et al.  Underdiagnosis and undertreatment of COPD in primary care settings , 2003, Respirology.

[14]  N. Chavannes,et al.  Detection of asthma and chronic obstructive pulmonary disease in primary care , 2003, European Respiratory Journal.

[15]  John E Connett,et al.  Smoking and lung function of Lung Health Study participants after 11 years. , 2002, American journal of respiratory and critical care medicine.

[16]  T. Seemungal,et al.  Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels , 2000, Thrombosis and Haemostasis.

[17]  T L Petty,et al.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.

[18]  T. Seemungal,et al.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.

[19]  W. Bailey,et al.  Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. , 2000, American journal of respiratory and critical care medicine.

[20]  V M Hawthorne,et al.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study , 1996, BMJ.

[21]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[22]  Margaret G. Stineman,et al.  Designing Clinical Research: An Epidemiological Approach , 1990 .

[23]  P. Schnohr,et al.  Spirometric findings and mortality in never-smokers. , 1990, Journal of clinical epidemiology.

[24]  K. Gunawardena,et al.  Evaluation of the turbine pocket spirometer. , 1987, Thorax.

[25]  M Terrin,et al.  Reference spirometric values using techniques and equipment that meet ATS recommendations. , 2015, The American review of respiratory disease.

[26]  R M Gardner,et al.  Reference spirometric values using techniques and equipment that meet ATS recommendations. , 2015, The American review of respiratory disease.

[27]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.